Germany Seeks Closer Partnership With Japan in Biopharmaceuticals

Informations

• Publié par: germany-trade-and-invest
• Nombre de lectures: 11
• Langue: English

Extrait

Germany Seeks Closer Partnership With Japan in Biopharmaceuticals

PR Newswire BERLIN and YOKOHAMA, Japan, October 9, 2012

BERLIN and YOKOHAMA, Japan,October 9, 2012/PRNewswire/ --

Health - Made in GermanyandGermany Trade & Investshare opportunities for joint R&D and investment

Germany Trade & Investand theHealth-Made in Germanyinitiative will join forces at this year's BioJapan 2012 fromOctober 10-12. In two seminars, guests from German and Japanese biotechnology companies,Germany's renowned Fraunhofer Insitute, and Germany Trade & Invest outline business opportunities for Japanese executives in the pharmaceutical and diagnostic fields.

"With world-class pharmaceutical industries and cutting-edge research, Germany and Japan are natural partners. Both countries are also facing the same challenges that come with aging societies. The conditions are just right to intensify cooperation in order to share costs and speed market entry," stated Iwami Asakawa,GermanyTrade & Investrepresentative in Tokyo.

Biotechnology cluster Bio-M in Munich and Cluster Osaka have been working together for a year. This best-practice example can serve as inspiration for other companies interested in expanding their reach.

Germany features over 550 dedicated biotechnology companies. Nearly half of these companies develop new drugs or diagnostic methods in the areas of human and animal medicine.

"In both countries, patent protection for several pharmaceuticals is running out. There is a need for innovation, and small and medium-sized companies have an excellent chance to work with established players. We see this as a tremendous opportunity for innovative biotechnology companies," comments Gabriel Flemming, medical biotechnology expert atGermany Trade & Investin Berlin.

Health-Made in Germanyis an initiative to create win-win situations for global partners and German health care companies. Supported by the Federal Ministry of Economics and Technology and carried out byGermany Trade & Invest, the initiative allows companies, federal clusters, and professional associations to benefit from business opportunities in the health care field.

Germany Trade & Investis the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest Andreas Bilfinger Email:[e-mail] T: [phone] http://www.gtai.com/press-subscription http://twitter.com/gtai_com http://youtube.com/gtai